Concepedia

Padmasini Kumar

PK

22

Publications

1.9K

Citations

19

H-Index

1996

Active since

Affiliations

Texas Oncology(Current)

Mary Crowley Cancer Research Center

Gradalis (United States)

Medical City Dallas Hospital

University of Oklahoma Health Sciences Center

Padmasini Kumar is an author at Texas Oncology specializing in medicine, immunology, and inflammation.

Top concepts

Publications per year

1996–2016

22

Publications

22

Lipopolysaccharides from Distinct Pathogens Induce Different Classes of Immune Responses In Vivo

Bali Pulendran, Padmasini Kumar, Christopher W. Cutler et al. · The Journal of Immunology · 2001 · 475 citations · Full text

Phase II Study of Belagenpumatucel-L, a Transforming Growth Factor Beta-2 Antisense Gene-Modified Allogeneic Tumor Cell Vaccine in Non–Small-Cell Lung Cancer

John Nemunaitis, Robert O. Dillman, Paul Schwarzenberger et al. · Journal of Clinical Oncology · 2006 · 358 citations · Full text

Phase I Trial of “bi-shRNAifurin/GMCSF DNA/Autologous Tumor Cell” Vaccine (FANG) in Advanced Cancer

Neil Senzer, Minal Barve, Joseph A. Kuhn et al. · Molecular Therapy · 2011 · 193 citations · Full text

Phase II trial of Belagenpumatucel-L, a TGF-β2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer (NSCLC) patients

John Nemunaitis, Michael Nemunaitis, Neil Senzer et al. · Cancer Gene Therapy · 2009 · 146 citations

, , +9

Phase II study of Vigil® DNA engineered immunotherapy as maintenance in advanced stage ovarian cancer

Jonathan Oh, Minal Barve, Carolyn M. Matthews et al. · Gynecologic Oncology · 2016 · 88 citations

, , +9

Rows per page

1–5 of 22